Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06299657 · ClinicalTrials.gov registry record · NA
Intervention for Managing Physical Reactions to Overwhelming Emotions
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT06299657 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 20 participants.
The verdict
NCT06299657, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The clinical trial aims to conduct a feasibility, acceptability, and usability clinical trial of a modular CBT-based and technologically enhanced intervention for people with an SUD and recently enrolled in IOP, probe target engagement and change in clinical outcomes, and examine attrition rates in IOP. This study will enroll 40 adults who are currently enrolled in IOP, have a substance use disorder, and experience elevated anxiety. 20 individuals will be randomized to the experimental intervention, "Intervention for Managing Physical Reactions to Overwhelming Emotions" (IMPROVE), and 20 individuals will be randomized to the active control group, "Physical Health Education Treatment" (PHET). Participants will be asked to complete a baseline assessment of mood, substance use, and psychophysiology. Participants will then completed ecological momentary assessments (EMA) via smartphone technology 4 times a day for \~ 28 days (the day following the baseline assessment until the 3rd intervention session). Participants will complete one 45 minute - 1 hour intervention each week for 3 weeks (either the IMPROVE or PHET intervention, pending randomization). Following the last intervention session, participants will return to the lab to complete a post-intervention assessment that mirrors the baseline assessment and then complete follow-up surveys 1- and 3-months post intervention.
Interventions
- BEHAVIORAL IMPROVE
- BEHAVIORAL PHET
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-03-07 |
| Est. Completion | 2025-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06299657
The ClinicalTrials.gov registry entry for NCT06299657 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which IMPROVE is the first listed.
NCT06299657 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06299657 about?
NCT06299657 is a clinical study titled "Intervention for Managing Physical Reactions to Overwhelming Emotions". The clinical trial aims to conduct a feasibility, acceptability, and usability clinical trial of a modular CBT-based and technologically enhanced intervention for people with an SUD and recently enrolled in IOP, probe target engagement and change in clinical outcomes, and examine attrition rates in ...
What is the current status of trial NCT06299657?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2024-03-07. Estimated completion is 2025-02-28.
What interventions are being tested in trial NCT06299657?
The interventions under investigation include: IMPROVE (BEHAVIORAL), PHET (BEHAVIORAL).
Who is sponsoring clinical trial NCT06299657?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.